Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Fortress Biotech revenue
Fortress Biotech's revenue is $84.5 million.
What is Fortress Biotech's revenue?
- Fortress Biotech's revenue growth from 2020 to 2023 is 85.34%.
- Fortress Biotech has 34 employees, and the revenue per employee ratio is $2,485,676.
- Fortress Biotech's peak quarterly revenue was $14.9M in 2024(q2).
- Fortress Biotech peak revenue was $84.5M in 2023.
- Fortress Biotech annual revenue for 2022 was 75.7M, 10.11% growth from 2021.
- Fortress Biotech annual revenue for 2023 was 84.5M, 11.58% growth from 2022.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Fortress Biotech historical revenue
Fortress Biotech's peak revenue was $84.5M in 2023. The peak quarterly revenue was $14.9M in 2024(q2).
Fortress Biotech's revenue increased from $45.6m in 2020 to $84.5M currently. That's a 85.34% change in annual revenue.
Fortress Biotech annual revenue
Fortress Biotech annual revenue over time
| Fiscal year / year | Fortress Biotech revenue |
|---|---|
| 2020 | $45.6M |
| 2021 | $68.8M |
| 2022 | $75.7M |
| 2023 | $84.5M |
How accurately did Fortress Biotech's revenue projections match actual performance?
Fortress Biotech annual growth
Fortress Biotech saw the greatest revenue growth in 2021, when revenue increased by 50.86%.
Fortress Biotech had the lowest revenue growth in 2022, when revenue changed by 10.11%.
Fortress Biotech annual growth rate over time
| Year | Fortress Biotech growth |
|---|---|
| 2021 | 51%↑ |
| 2022 | 10%↑ |
| 2023 | 12%↑ |
Fortress Biotech jobs nearby
Do you work at Fortress Biotech?
Is Fortress Biotech transparent about its revenue structure?
Fortress Biotech financial information
| CEO | Lindsay A. Rosenwald M.d |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 34 |
| Date Founded | 2006 |
| Headquarters | New York, New York |
| Number of Locations | 3 |
| Revenue | $84.5M |
| Net Income | -$86,575,000 |
| Gross Proft | $57.9M (2023) |
| PE Ratio | -3.23 |
| Tax Rate | -0.0% |
| Market Capitalization | $196.0M |
| Total Assets | $294,301,000 |
| Ticker | FBIO |
Fortress Biotech jobs you might like
Fortress Biotech financing
Fortress Biotech received early financing of $1.2M on 2009-08-04.
| Series | Round size | Date |
|---|---|---|
| Convertible Note | $1.2M | 08/2009 |
| Series C | $3.9M | 07/2010 |
| Series Unknown | $17.7M | 11/2010 |
| Series Unknown | $14.1M | 01/2011 |
| Series C | $25.8M | 07/2011 |
| Post Ipo Debt | $15M | 08/2012 |
| Post Ipo Debt | $6.5M | 03/2018 |
| Post Ipo Equity | $14.4M | 02/2020 |
| Post Ipo Debt | $60M | 08/2020 |
Fortress Biotech investors
| Investors | Security type |
|---|---|
| National Securities Corporation | Series C |
| HERCULES CAPITAL INC | Post Ipo Debt |
| Oaktree Capital Management | Post Ipo Debt |
Fortress Biotech competitors
Fortress Biotech's top competitor, Merck, earned an annual revenue of $64.2B.
Fortress Biotech's smallest competitor is Nektar Therapeutics with revenue of $98.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Regeneron | $85,589 | $14.2B | 9,123 | 341 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 745 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,144 |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 24 |
| Hospira | $64,435 | $4.5B | 19,000 | - |
| Nektar Therapeutics | $83,561 | $98.4M | 718 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 243 |
| Zoetis | $87,092 | $9.3B | 11,300 | 207 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Fortress Biotech, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Fortress Biotech. The employee data is based on information from people who have self-reported their past or current employments at Fortress Biotech. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Fortress Biotech. The data presented on this page does not represent the view of Fortress Biotech and its employees or that of Zippia.
Fortress Biotech may also be known as or be related to Fortress Biotech, Fortress Biotech Inc, Fortress Biotech Inc. and Fortress Biotech, Inc.